/Gregory Downey/ - 29 Aug 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Chief Financial Officer
Signature
/Gregory Downey/
Issuer symbol
LEXX
Transactions as of
29 Aug 2022
Net transactions value
$0
Form type
4
Filing time
29 Aug 2022, 17:08:47 UTC
Previous filing
02 Sep 2021
Next filing
18 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 1,833 29 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +11,000 +31% $0.000000 46,000 29 Aug 2022 Common Shares 11,000 $2.91 Direct
holding LEXX Stock Options 4,000 29 Aug 2022 Common Shares 4,000 $5.04 Direct
holding LEXX Stock Options 8,000 29 Aug 2022 Common Shares 4,000 $5.04 Direct
holding LEXX Stock Options 12,000 29 Aug 2022 Common Shares 4,000 $5.04 Direct
holding LEXX Stock Options 17,000 29 Aug 2022 Common Shares 5,000 $5.31 Direct
holding LEXX Stock Options 25,000 29 Aug 2022 Common Shares 8,000 $7.08 Direct
holding LEXX Stock Options 35,000 29 Aug 2022 Common Shares 10,000 $6.23 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.